FACTANKER

iTeos Therapeutics, Inc.: cashflow_investing

Value{"amount": -53278000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2024-01-01 – 2024-06-30
Statuscurrent
EntityiTeos Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-24-093302
Retrieved: 2026-08-19T18:13:05.345676+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/ceb2740b-4499-4bc5-9c3c-fe402af4d5b2

History